Pharmaceutical Strategies Group Announces Strategic Leadership Enhancements to Meet Growing Client Needs
May 06 2024 - 10:00AM
Business Wire
Pharmaceutical Strategies Group (“PSG”), an EPIC company, has
added two significant enhancements to its leadership team aimed at
further empowering healthcare payers and driving innovation within
the pharmacy benefits industry. The company welcomes Mike Sackett
as SVP of Financial Analytics, Procurement, and Consulting Strategy
and celebrates the well-deserved promotion of Rebekah Gregg to
Chief Operating Officer.
"The addition of Mike Sackett to our team and the promotion of
Rebekah Gregg mark strategic organizational changes that underscore
our commitment to growth and our dedication to providing
market-leading solutions,” said Michael Lonergan, President of PSG.
“With these leadership enhancements, we are better positioned than
ever to help our clients navigate the complexities of the pharmacy
supply chain, driving both innovation and success."
With nearly a quarter century of experience in pharmacy
benefit-related financial analytics, Sackett’s career, spanning
various leadership roles across several of the industry's top
organizations, has equipped him with unparalleled expertise in the
financial and economic dynamics of the pharmacy benefits market. As
the latest addition to the PSG team, Mike will spearhead the
financial analytics, procurement, and audit functions, working
closely with the senior leadership team to drive innovation,
development, and execution of PSG's financial insight products and
services. These efforts aim to enhance strategic decision-making
for healthcare payers, ensuring their pharmacy benefit programs
align with their overarching goals.
“It is an exciting time in the pharmacy benefits landscape, and
I am thrilled to contribute my expertise in pharmacy-related
strategy to further enhance our capabilities and drive
transformative solutions for our clients," said Sackett. “PSG has
been a leader in the pharmacy benefits industry, and I look forward
to being a part of its continued success.”
In recognition of her expanded role and contribution to the
company, Rebekah Gregg has been promoted to the role of Chief
Operating Officer. Gregg’s time at PSG has been marked by
significant growth in her scope and span of control, making this
promotion a reflection of her current leadership. As COO, Rebekah
will oversee PSG’s marketing, research, data analytics, clinical
shared services, and product strategy, including Artemetrx, further
solidifying PSG's position at the forefront of the industry.
Gregg noted, "I am truly honored to step into the role of COO of
PSG. Our organization has a rich legacy of innovation and
excellence, and I am excited to help continue that work and
contribute to our team's efforts in empowering our clients and
shaping the future of pharmacy benefits management."
About Pharmaceutical Strategies Group (PSG)
Pharmaceutical Strategies Group, an EPIC company, relentlessly
advocates for clients as they navigate complex and ever-changing
drug cost management challenges. PSG functions as a strategic
partner through industry-leading intelligence and technologies to
realize billions of dollars in drug cost savings for clients every
year. www.psgconsults.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240506191405/en/
Media Kara Lester Gregory FCA for PSG EPIC@gregoryfca.com
267-503-4770